| Style | Citing Format |
|---|---|
| MLA | Khosravi S, et al.. "Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With Jak2v617f-Negative Polycythemia Vera." Hematology/ Oncology and Stem Cell Therapy, vol. 17, no. 2, 2024, pp. 154-158. |
| APA | Khosravi S, Chahardouli B, Ebrahimi P, Babaei FN, Alimoghadam K, Rostami S (2024). Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With Jak2v617f-Negative Polycythemia Vera. Hematology/ Oncology and Stem Cell Therapy, 17(2), 154-158. |
| Chicago | Khosravi S, Chahardouli B, Ebrahimi P, Babaei FN, Alimoghadam K, Rostami S. "Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With Jak2v617f-Negative Polycythemia Vera." Hematology/ Oncology and Stem Cell Therapy 17, no. 2 (2024): 154-158. |
| Harvard | Khosravi S et al. (2024) 'Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With Jak2v617f-Negative Polycythemia Vera', Hematology/ Oncology and Stem Cell Therapy, 17(2), pp. 154-158. |
| Vancouver | Khosravi S, Chahardouli B, Ebrahimi P, Babaei FN, Alimoghadam K, Rostami S. Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With Jak2v617f-Negative Polycythemia Vera. Hematology/ Oncology and Stem Cell Therapy. 2024;17(2):154-158. |
| BibTex | @article{ author = {Khosravi S and Chahardouli B and Ebrahimi P and Babaei FN and Alimoghadam K and Rostami S}, title = {Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With Jak2v617f-Negative Polycythemia Vera}, journal = {Hematology/ Oncology and Stem Cell Therapy}, volume = {17}, number = {2}, pages = {154-158}, year = {2024} } |
| RIS | TY - JOUR AU - Khosravi S AU - Chahardouli B AU - Ebrahimi P AU - Babaei FN AU - Alimoghadam K AU - Rostami S TI - Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With Jak2v617f-Negative Polycythemia Vera JO - Hematology/ Oncology and Stem Cell Therapy VL - 17 IS - 2 SP - 154 EP - 158 PY - 2024 ER - |